» Authors » Ruiming Rong

Ruiming Rong

Explore the profile of Ruiming Rong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 1057
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Niu X, Xu X, Xu C, Cheuk Y, Rong R
Bioengineering (Basel) . 2024 May; 11(5). PMID: 38790298
Renal fibrosis is a pathological endpoint of maladaptation after ischemia-reperfusion injury (IRI), and despite many attempts, no good treatment has been achieved so far. At the core of renal fibrosis...
2.
Xu C, Chen J, Liang L, Chen S, Niu X, Sang R, et al.
Commun Biol . 2024 May; 7(1):544. PMID: 38714800
Numerous myofibroblasts are arisen from endothelial cells (ECs) through endothelial to mesenchymal transition (EndMT) triggered by TGF-β. However, the mechanism of ECs transforms to a different subtype, or whether there...
3.
Niu X, Xu C, Cheuk Y, Xu X, Liang L, Zhang P, et al.
J Transl Med . 2024 Feb; 22(1):186. PMID: 38378674
Background: Kidney transplantation stands out as the most effective renal replacement therapy for patients grappling with end-stage renal disease. However, post-transplant renal fibrosis is a prevalent and irreversible consequence, imposing...
4.
Xu C, Chen S, Chen J, Wang J, Niu X, Rong R, et al.
Biomark Res . 2024 Jan; 12(1):9. PMID: 38245774
Uncontrolled productive infection of BK polyomaviruses (BKV) in immunocompromised patients was reported to result in serious diseases, especially renourinary malignancies. However, the mechanism of BKV as a role of human...
5.
Luo Y, Zhang K, Wu J, Zeng H, Chen J, Zhang P, et al.
Ren Fail . 2023 May; 45(1):2212079. PMID: 37218597
Background: Mesenchymal stem cells (MSCs) are the hotspots of cellular therapy due to their low immunogenicity, potent immunoregulation, and unique renoprotection. The present study aimed to investigate the effects of...
6.
Chen J, Xu C, Yang K, Gao R, Cao Y, Liang L, et al.
Nat Commun . 2023 Mar; 14(1):1161. PMID: 36859428
Ischemia reperfusion injury (IRI) is a common cause of acute kidney injury (AKI). The role of Nmethyladenosine (m6A) modification in AKI remains unclear. Here, we characterize the role of AlkB...
7.
Niu X, Cheuk Y, Li X, Rong R, Xu X, Xu C, et al.
Biomolecules . 2023 Feb; 13(2). PMID: 36830644
Ischemia-reperfusion injury (IRI) often occurs in the process of kidney transplantation, which significantly impacts the subsequent treatment and prognosis of patients. The prognosis of patients with different subtypes of IRI...
8.
Xu S, Cheuk Y, Jia Y, Chen T, Chen J, Luo Y, et al.
Cell Death Dis . 2022 Oct; 13(10):876. PMID: 36253358
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis. Mesenchymal stem cell-derived exosomes (MSC-Exos)...
9.
Chen T, Li X, Wang J, Wang X, Zhu T, Rong R, et al.
Front Immunol . 2022 Oct; 13:1017872. PMID: 36211389
A 66-year-old Chinese man underwent a deceased donor kidney transplantation. Induction-immunosuppressive protocol consisted of basiliximab (BAS) and methyl prednisolone (MP), followed by maintenance immunosuppression with cyclosporin (CsA), mycophenolate mofetil (MMF),...
10.
Cheuk Y, Niu X, Mao Y, Li J, Wang J, Xu S, et al.
Cell Tissue Res . 2022 Sep; 390(3):465-489. PMID: 36098854
Overexposure to transforming growth factor b1 (TGF-β1) induces myofibroblastic differentiation of mesenchymal stem cells (MSCs), which could be attenuated by myeloid-derived suppressor cell (MDSC) supernatant. However, the promyofibroblastic effects of...